1. Home
  2. ECF vs VCEL Comparison

ECF vs VCEL Comparison

Compare ECF & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ellsworth Growth and Income Fund Ltd.

ECF

Ellsworth Growth and Income Fund Ltd.

HOLD

Current Price

$11.87

Market Cap

161.3M

Sector

Finance

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$37.52

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ECF
VCEL
Founded
1986
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
161.3M
2.0B
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
ECF
VCEL
Price
$11.87
$37.52
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$57.50
AVG Volume (30 Days)
57.7K
599.1K
Earning Date
01-01-0001
11-06-2025
Dividend Yield
6.42%
N/A
EPS Growth
N/A
236.54
EPS
0.46
0.25
Revenue
N/A
$258,716,999.00
Revenue This Year
N/A
$17.86
Revenue Next Year
N/A
$18.55
P/E Ratio
$17.61
$152.71
Revenue Growth
N/A
14.05
52 Week Low
$7.02
$29.24
52 Week High
$8.91
$63.00

Technical Indicators

Market Signals
Indicator
ECF
VCEL
Relative Strength Index (RSI) 52.59 50.86
Support Level $11.74 $35.53
Resistance Level $11.95 $38.15
Average True Range (ATR) 0.22 1.31
MACD 0.02 0.07
Stochastic Oscillator 72.97 69.31

Price Performance

Historical Comparison
ECF
VCEL

About ECF Ellsworth Growth and Income Fund Ltd.

Ellsworth Growth and Income Fund Ltd operate as a closed-end, diversified management investment company. Its investment objective is to provide income and the potential for capital appreciation, which objectives the Fund considers to be relatively equal over the long term due to the nature of the securities in which it invests. The company invests in convertible and equity securities. It invests in various sectors, such as healthcare, financial services, computer software and services, energy and utilities, real estate investment trusts, semiconductors, telecommunications, business services, food and beverage, consumer products, transportation, consumer services among others.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: